SUBSCRIPTION AGREEMENTSubscription Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments
The undersigned, Richard Kaiser, hereby subscribes to 500,000 shares of the $0.0001 par value Preferred Series ‘A’ stock (the "Shares") of BioForce Nanosciences Holdings, Inc. (BFNH) a corporation duly organized under the laws of the State of Nevada, (the "Company").
Director/ Chief Financial Officer/ Secretary Compensation AGREEMENTDirector Compensation Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware
This Director, Chief Financial Officer/ Secretary (DCFOS) Compensation Agreement (this “Agreement”) is made as of the 31st day of March 2020 by and among Bioforce Nanosciences Holdings, Inc. (BFNH) a Delaware Corporation, having its principal place of business at 2020 General Booth Blvd., Unit 230 Virginia Beach, VA 23454 (“Company”), and Richard Kaiser Director, Chief Financial Officer/ Secretary, and is made in light of the following recitals which are a material part hereof.
RSDL ENTERPRISES CONSULTING AGREEMENTConsulting Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Virginia
Chairman of the Board/ President/CEO Compensation AGREEMENTChairman and President Compensation Agreement • May 4th, 2020 • Bioforce Nanosciences Holdings, Inc. • Laboratory analytical instruments • Delaware
This Chairman and President Compensation Agreement (this “Agreement”) is made as of the 31st day of March, 2020 by and among Bioforce Nanosciences Holdings, Inc. (BFNH) a Nevada Corporation, having its principal place of business at 2020 General Booth Blvd., Unit 230 Virginia Beach, VA 23454 (“Company”), and Merle Ferguson, Chairman of Board (Chairman) and President and CEO, and is made in light of the following recitals which are a material part hereof.
